Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment. | Cells | 2023 | 38067177 | PubTator, text mining | PubMed |
| Comprehensive characterization of adipogenesis-related genes in colorectal cancer for clinical significance and immunogenomic landscape analyses. | Lipids Health Dis | 2023 | 38062499 | PubTator, text mining | PubMed |
| Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus. | Front Bioeng Biotechnol | 2023 | 38053848 | PubTator, text mining | PubMed |
| TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion. | iScience | 2023 | 38047087 | PubTator, text mining | PubMed |
| Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy. | MedComm (2020) | 2023 | 38045827 | PubTator, text mining | PubMed |
| Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | 38045198 | PubTator, text mining | PubMed |
| CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? | Hemasphere | 2023 | 38044959 | PubTator, text mining | PubMed |
| Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges. | Biomark Res | 2023 | 38037114 | PubTator, text mining | PubMed |
| CAR-T cell therapy for hematological malignancies: History, status and promise. | Heliyon | 2023 | 38027932 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| Editorial: TNFRSF agonists: mode of action and therapeutic opportunities. | Front Immunol | 2023 | 38022660 | PubTator, text mining | PubMed |
| Interrogating ligand-receptor interactions using highly sensitive cellular biosensors. | Nat Commun | 2023 | 38016944 | PubTator, text mining | PubMed |
| Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning. | Medicine (Baltimore) | 2023 | 38013352 | PubTator, text mining | PubMed |
| GPNMB+ Gal-3+ hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis. | EMBO J | 2023 | 38009297 | PubTator, text mining | PubMed |
| Therapeutic avenues for γδ T cells in cancer. | J Immunother Cancer | 2023 | 38007241 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma. | J Pers Med | 2023 | 38003910 | PubTator, text mining | PubMed |
| ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. | Int J Mol Sci | 2023 | 38003570 | PubTator, text mining | PubMed |
| Future prospects in radiation oncology from the perspective of innovative radiation biology. | Strahlenther Onkol | 2023 | 38001382 | PubTator, text mining | PubMed |
| Construction and evaluation of a novel prognostic risk model of aging-related genes in bladder cancer. | Curr Urol | 2023 | 37994343 | PubTator, text mining | PubMed |
| GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. | Cell Rep Med | 2023 | 37992682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=13